Table:
begin	end	state
1	19	non-cytoplasmic
20	20	cytoplasmic
21	43	transmembrane
44	48	cytoplasmic
49	69	transmembrane
70	81	non-cytoplasmic
82	100	transmembrane
101	121	non-cytoplasmic
122	149	transmembrane
150	157	cytoplasmic
158	179	transmembrane
180	198	non-cytoplasmic
199	219	transmembrane
220	248	cytoplasmic
249	271	transmembrane
272	282	non-cytoplasmic
283	307	transmembrane
308	322	cytoplasmic
323	341	transmembrane
342	354	non-cytoplasmic
355	375	transmembrane
376	381	cytoplasmic
382	402	transmembrane
403	407	non-cytoplasmic
408	430	transmembrane
431	441	cytoplasmic
442	463	transmembrane
464	467	non-cytoplasmic

Input:
>GFF4613 FitnessBrowser__WCS417:GFF4613
MIYEFHNQFDVTLSEEYRMAASPGFGLLAYAAIAIIALIVLIARYRLNPFIVITLVSIGL
ALMAGMPADTIMGSYEAGVGKTLGHIALVVALGTMLGKMMAESGGAEQVARTLINRFGER
NAHWAMVCIAFLVGLPLFFEVGFVLLVPIAFTVARRVGVSILMVGLPMVAGLSVVHALVP
PHPAAMMAVLAYNASVGQTVLYAILIGIPTAIIAGPVYAKFIVPRIHLPAENPLERQFID
REPRTRLPSFTLTMGTILLPVVLMMIGGWANVISSPGSAFNQFLLFIGNSVIALLVATLV
SFWTLGIAQGFNRESILKFTNECLAPTASITLLVGAGGGLNRILVDAGVTNEILGLAHAF
QLSPLVMGWLFAALMRIATGSATVAMTTASGVVAPVAMGLGYPHPELLVLATGAGSVIFS
HVNDGGFWLIKEYFNMTVIQTFKTWTVLETLISVVAFGLTYGLSCIL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server